Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04318470 · ClinicalTrials.gov registry record
Identification of Microbial DNA in Maternal Plasma After PPROM
A clinical trial of Preterm Rupture of Membranes, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 70
- Enrollment target
- 1
- Study location
NCT04318470 is a study of Preterm Rupture of Membranes that has completed, run by University of California, San Francisco. The registered enrollment target is 70 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04318470, a study of Preterm Rupture of Membranes, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates the use of metagenomic next generation sequencing in identifying microbial DNA in plasma samples of patients with preterm premature rupture of membranes.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST mNGS
Study Locations (1)
California
- University of California, San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2020-02-12 |
| Est. Completion | 2022-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04318470
The ClinicalTrials.gov registry entry for NCT04318470 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Preterm Rupture of Membranes appearing as the primary indexed condition, and to 1 intervention - of which mNGS is the first listed.
NCT04318470 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04318470 about?
NCT04318470 is a clinical study titled "Identification of Microbial DNA in Maternal Plasma After PPROM". This study evaluates the use of metagenomic next generation sequencing in identifying microbial DNA in plasma samples of patients with preterm premature rupture of membranes.
What is the current status of trial NCT04318470?
This trial is currently completed. The enrollment target is 70 participants. The study started on 2020-02-12. Estimated completion is 2022-12-31.
What conditions does trial NCT04318470 study?
This clinical trial studies the following conditions: Preterm Rupture of Membranes.
What interventions are being tested in trial NCT04318470?
The interventions under investigation include: mNGS (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04318470?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04318470 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.